Characterisation of bone marrow soluble factors and mesenchymal stem cells in B-cell acute lymphoblastic leukaemia
Access Status
Fulltext not available
Embargo Lift Date
2025-06-08
Date
2023Supervisor
Laurence Cheung
Rishi Kotecha
Type
Thesis
Award
PhD
Metadata
Show full item recordFaculty
Health Sciences
School
Curtin Medical School
Collection
Abstract
This thesis provides novel insight into the complexity of the bone marrow environment of B-cell acute lymphoblastic leukaemia or B-ALL, the most common cancer in children. Specifically, my project characterised bone marrow soluble factors during disease development. Furthermore, we identified cellular and molecular changes in leukaemia-associated mesenchymal stem cells. In conclusion, this study provides further understanding of B-ALL biology and has brought us closer to exploiting new therapeutic targets to treat children with leukaemia.
Related items
Showing items related by title, author, creator and subject.
-
Wells, J.; Howlett, M.; Halse, H.; Heng, J.; Ford, J.; Cheung, Laurence; Samuels, A.; Crook, M.; Charles, A.; Cole, C.; Kees, U. (2016)To improve treatment of acute lymphoblastic leukaemia (ALL), a better understanding of disease development is needed to tailor new therapies. Connective tissue growth factor (CTGF/CCN2) is highly expressed in leukaemia ...
-
Karsa, Mawar; Kosciolek, Angelika; Bongers, Angelika; Mariana, Anna; Failes, Tim; Gifford, Andrew J; Kees, Ursula R; Cheung, Laurence ; Kotecha, Rishi ; Arndt, Greg M; Haber, Michelle; Norris, Murray D; Sutton, Rosemary; Lock, Richard B; Henderson, Michelle J; Somers, Klaartje (2021)BACKGROUND: The prognosis for high-risk childhood acute leukaemias remains dismal and established treatment protocols often cause long-term side effects in survivors. This study aims to identify more effective and safer ...
-
Kuek, V.; Hughes, A.M.; Kotecha, Rishi ; Cheung, Laurence (2021)In recent decades, the conduct of uniform prospective clinical trials has led to improved remission rates and survival for patients with acute myeloid leukaemia and acute lymphoblastic leukaemia. However, high-risk patients ...